Related Experiment Video
Updated: Jul 19, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Insurance coverage for obesity treatment
Adam Gilden Tsai1, David A Asch, Thomas A Wadden
1Center for Weight and Eating Disorders, University of Pennsylvania, Philadelphia 19104, USA. gildena@mail.med.upenn.edu
Journal of the American Dietetic Association
|September 27, 2006
Summary
Pennsylvania insurers offer limited coverage for intensive weight loss counseling and lifestyle modification programs, despite evidence of their benefits. Bariatric surgery is more consistently reimbursed than other obesity treatments.
Area of Science:
- Health Services Research
- Obesity Medicine
- Health Policy Analysis
Background:
- Intensive lifestyle modification demonstrates significant benefits for weight loss.
- Lack of insurance reimbursement presents a barrier to obesity counseling.
- Understanding current insurance coverage policies is crucial for patient access to care.
Purpose of the Study:
- To quantify the obesity coverage policies of health insurance plans in Pennsylvania.
- To assess the extent of reimbursement for various weight loss treatment modalities.
- To compare insurance coverage for surgical versus non-surgical obesity treatments.
Main Methods:
- A questionnaire was distributed to eligible Pennsylvania health plans.
- Data were collected from medical directors and administrators regarding coverage details.
- Sixteen out of 19 (84%) health plans responded to the survey.
Main Results:
- All responding plans covered bariatric surgery.
- Only 56% covered individual dietary counseling, with just five plans covering intensive counseling.
- Reimbursement for lifestyle modification and weight loss medication was less than 50%.
Conclusions:
- Insurance reimbursement in Pennsylvania inadequately reflects the evidence supporting lifestyle modification for obesity.
- Bariatric surgery is significantly more covered than other obesity treatments.
- Coverage policies may need to evolve to align with the clinical and cost-effectiveness of non-surgical weight loss therapies.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...